Feng Zeng is a seasoned professional in health economics and outcomes research, currently serving as the Value Evidence Strategy Lead for Lupus and the Therapeutic Area Head for Multiple Sclerosis at Biogen since January 2021. Prior experience includes leadership roles at EMD Serono, Inc. as Strategy Lead and Director of Global Evidence and Value Development in Neurology, and at La Jolla Pharmaceutical Company as Director of Health Economics and Real-World Evidence. Feng Zeng has also held positions at West Health, MedImpact, and Thomson Medstat, focusing on health economics analysis for diverse stakeholders. Academic experience includes a Postdoctoral Research Associate role at the University of Southern California, with a Ph.D. in Policy Analysis from the RAND School of Public Policy.
This person is not in any teams
This person is not in any offices